- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Zalicus Inc+ Add to Watchlist
ZLCS:US1.2100 USD 0.0600 5.22%
As of 20:10:00 ET on 04/22/2014.
Company Profile for Zalicus Inc (ZLCS)
Zalicus Inc is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. The Company's drug pipeline includes an arthritis formula in phase 2 development.
Key Executives for Zalicus Inc (ZLCS)
|Mark H N CorriganPresident/CEO||Justin A RenzExec VP/CFO/Treasurer|